Select Page

ETF innovation is truly staggering.  After hosting ETF Prime for 7+ years and visiting weekly with the brightest minds the industry has to offer, I can only compare the sheer level of talent and entrepreneurial spirit to Silicon Valley.  With so many unique and interesting ETF stories, I thought it would be fun to occasionally venture down the rabbit hole and delve deeper into areas I personally find fascinating.

This week, Brad Loncar, a Kansas City native and biotech investing expert, takes us into the world of China biotech.  While Brad would never say this, I consider Brad among the smartest biotech investors I have ever met.  Brad developed the indexes behind the Loncar Cancer Immunotherapy ETF (CNCR) and the recently launched China BioPharma ETF (CHNA).  If you have any interest in biotech whatsoever, I think you’ll find this conversation insightful.  Hope you enjoy!